Multiple sclerosis: assay of free immunoglobulin light chains.

@article{Ramsden2017MultipleSA,
  title={Multiple sclerosis: assay of free immunoglobulin light chains.},
  author={David Boyer Ramsden},
  journal={Annals of clinical biochemistry},
  year={2017},
  volume={54 1},
  pages={
          5-13
        }
}
Over the past five years, a number of papers have appeared describing the assay of free immunoglobulin light chains in cerebrospinal fluid to assist in the diagnosis of multiple sclerosis. The assay of kappa free immunoglobulin chains is being advocated as a technically simpler and cheaper quantitative alternative to the qualitative detection of oligoclonal bands. This article reviews the analytical and clinical characteristics of these immunoglobulin free light chain assays and places them in… CONTINUE READING
BETA
3
Twitter Mentions

Similar Papers

Topics from this paper.

Citations

Publications citing this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 50 REFERENCES

Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis

S Presslauer, D Milosavljevic, T Brücke
  • J Neurol 2008;255:1508–14
  • 2008
VIEW 12 EXCERPTS
HIGHLY INFLUENTIAL

Oligoclonal free light chains in cerebrospinal fluid as markers of intrathecal inflammation. Comparison with oligoclonal IgG.

  • Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
  • 2014
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL